Brief: Zynerba Pharmaceuticals Reports First Quarter 2020 Results
11/05/2020 13:23
May 11 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2020
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* Q1 LOSS PER SHARE $0.53
* Q1 EARNINGS PER SHARE ESTIMATE $-0.50 -- REFINITIV IBES
DATA
* ZYNERBA - BELIEVES CASH RUNWAY SUFFICIENT TO FUND
OPERATIONS
BEYOND EXPECTED NDA SUBMISSION, POTENTIAL APPROVAL OF ZYGEL IN
FXS & INTO H2 2021
Source text for Eikon: ID:nGNX34cwvr
Further company coverage: ZYNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary